Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
Open Access
- 17 April 1998
- journal article
- predictive oncology
- Published by Wiley in International Journal of Cancer
- Vol. 79 (2), 179-186
- https://doi.org/10.1002/(sici)1097-0215(19980417)79:2<179::aid-ijc14>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Vascular endothelial growth factor expression in primary esophageal squamous cell carcinomaCancer, 1997
- Expression of tissue‐type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on matrigelJournal of Cellular Physiology, 1995
- Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.JCI Insight, 1993
- Prevention of metastasis by inhibition of the urokinase receptor.Proceedings of the National Academy of Sciences, 1993
- Microvessel quantitation and prognosis in invasive breast carcinomaHuman Pathology, 1992
- Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumoursEuropean Journal of Cancer and Clinical Oncology, 1991
- Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cellsBlood, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Plasminogen Activators, Tissue Degradation, and CancerAdvances in Cancer Research, 1985